IM Cannabis (NASDAQ:IMCC) & Modular Medical (NASDAQ:MODD) Head-To-Head Survey

IM Cannabis (NASDAQ:IMCC) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares IM Cannabis and Modular Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IM Cannabis	$39.17 million	0.05	-$8.10 million	($1.75)	-0.17
Modular Medical	N/A	N/A	-$18.82 million	($14.71)	-0.31

IM Cannabis has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for IM Cannabis and Modular Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IM Cannabis	1	0	0	0	1.00
Modular Medical	1	0	0	0	1.00

Risk and Volatility

IM Cannabis has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.31, indicating that its share price is 69% less volatile than the S&P 500.

Insider & Institutional Ownership

7.7% of IM Cannabis shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 5.9% of IM Cannabis shares are owned by company insiders. Comparatively, 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares IM Cannabis and Modular Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IM Cannabis	-27.65%	-585.96%	-39.96%
Modular Medical	N/A	-245.85%	-190.80%

Summary

IM Cannabis beats Modular Medical on 6 of the 10 factors compared between the two stocks.

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

About Modular Medical

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.